Post-earnings recap
Reported
Mon, Nov 3, 2025
EPS actual
$0.02
EPS est.
$-0.34
EPS surprise
+105.88%
1-day move
+1.92%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a positive surprise on EPS, which contributed to a 1.92% increase in stock price. However, no revenue figures were provided, leaving some uncertainty about overall performance. Investors may be encouraged by the EPS beat but will likely look for more information in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.02 | N/A | +105.88% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.